3rd New Product Planning Summit – 3rd New Product Planning Summit
Brand commercialization teams often include representatives from a wide range of functions who weigh in at different stages of the product’s life cycle to determine the best strategy from preclinical through post-product launch. Since each product has its own set of unique challenges, no two companies follow the same approach, and there is a growing need to understand external market dynamics and learn how to leverage competitive intelligence to ensure the successful launch of a product.
The 3rd New Product Planning Summit will bring together cross-functional stakeholders from product development teams at biopharma, medical device, and large pharmaceutical companies and discuss key strategies to effectively commercialize a new product. Join our esteemed speaking faculty as they explore the differences in roles and responsibilities of new product planning professionals based on company size and culture, and share valuable insights and best practices to employ at different stages of a product’s life cycle.
Top Five Reasons to Attend
Learn about perspectives and best practices for new product planning from across different therapeutic areas, geographies and healthcare segments
Examine portfolio optimization and prioritization metrics that demonstrate the value of pipeline planning and support business cases for new products
Develop a global marketing communication and a launch strategy that is impactful and tailored to the needs of regional affiliates
Explore the use of real-world evidence to enhance the value proposition of new products
Examine how new product planning functions are structured, governed and operate at various companies and the key challenges they face
Who Should Attend
This conference is designed for representatives from pharmaceutical, biotechnology and medical device companies with responsibilities in the following areas:
The 3rd New Product Planning Summit will feature strategies and insights from cross-functional industry experts responsible for new product development, commercialization, life cycle management and strategic portfolio planning in the life science industry.